Search details
1.
A nationwide pilot study on breast cancer screening in Peru.
Ecancermedicalscience
; 17: 1494, 2023.
Article
in English
| MEDLINE | ID: mdl-36816782
2.
Influence of Sex in the Molecular Characteristics and Outcomes of Malignant Tumors.
Front Oncol
; 11: 752918, 2021.
Article
in English
| MEDLINE | ID: mdl-34737960
3.
Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer.
Clin Med Insights Oncol
; 13: 1179554919868482, 2019.
Article
in English
| MEDLINE | ID: mdl-31447598
4.
Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America.
Ecancermedicalscience
; 13: 896, 2019.
Article
in English
| MEDLINE | ID: mdl-30792813
5.
Helicobacter pylori: History and facts in Peru.
Crit Rev Oncol Hematol
; 134: 22-30, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30771870
6.
Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial.
Clin Cancer Res
; 25(2): 771-783, 2019 01 15.
Article
in English
| MEDLINE | ID: mdl-30274983
7.
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer.
Nat Commun
; 10(1): 1373, 2019 03 26.
Article
in English
| MEDLINE | ID: mdl-30914635
8.
ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors.
Clin Cancer Res
; 24(11): 2517-2529, 2018 06 01.
Article
in English
| MEDLINE | ID: mdl-29581135
9.
An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression.
J Natl Cancer Inst
; 109(11)2017 11 01.
Article
in English
| MEDLINE | ID: mdl-29059433
10.
Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER+ Breast Cancer.
Clin Cancer Res
; 23(20): 6138-6150, 2017 Oct 15.
Article
in English
| MEDLINE | ID: mdl-28751448
11.
MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation.
Cell Metab
; 26(4): 633-647.e7, 2017 Oct 03.
Article
in English
| MEDLINE | ID: mdl-28978427
12.
Maybe we don't know JAK?
Mol Cell Oncol
; 3(4): e1192713, 2016 Jul.
Article
in English
| MEDLINE | ID: mdl-27652332
13.
Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence.
Sci Transl Med
; 8(334): 334ra53, 2016 Apr 13.
Article
in English
| MEDLINE | ID: mdl-27075627
14.
LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
J Clin Invest
; 124(12): 5490-502, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25401474
15.
Correction: ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors.
Clin Cancer Res
; 25(4): 1431, 2019 Feb 15.
Article
in English
| MEDLINE | ID: mdl-30770490
16.
Correction: Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER+ Breast Cancer.
Clin Cancer Res
; 25(4): 1433, 2019 Feb 15.
Article
in English
| MEDLINE | ID: mdl-30770492
17.
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets.
Cancer Discov
; 4(2): 232-45, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24356096
18.
Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.
Cancer Res
; 73(20): 6346-58, 2013 Oct 15.
Article
in English
| MEDLINE | ID: mdl-23966295
Results
1 -
18
de 18
1
Next >
>>